Agilent 4150 Tape Station System, Consumables, Accessories, and Maintenance Services

The U.S. Food and Drug Administration (FDA) is seeking a Blanket Purchase Agreement (BPA) for the procurement of Agilent 4150 TapeStation System instrumentation, proprietary consumables, accessories, replacement parts, and associated maintenance and support services. The BPA will cover five categories of products and services, including Agilent TapeStation instrumentation, proprietary Agilent ScreenTape consumables and reagents, accessories and replacement parts, maintenance and support services, and software and firmware. The FDA requires vendors to be registered and active in the System for Award Management (SAM), be a current authorized Agilent reseller and/or service provider, and demonstrate past performance in the successful delivery, installation, and maintenance of an Agilent 4150 TapeStation System or equivalent. Key points to consider: • The BPA will be for a period of five years from the effective date, with no option years. • The acquisition strategy is a Total Small Business Set-Aside under FAR Part 12 (Commercial Products and Services). • The contract type will be a Firm-Fixed-Price Blanket Purchase Agreement (BPA). • The basis for award will be the lowest-priced, technically acceptable (LPTA) offer, with technical capability being significantly more important than price. • Vendors must demonstrate the ability to provide genuine Agilent OEM products and services across all five categories. • Vendors must comply with all applicable Buy American Act (BAA) requirements.